Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease

NCT: NCT03241420 · ACTIVE_NOT_RECRUITING

NCT IDNCT03241420
StatusACTIVE_NOT_RECRUITING
Start Date2017-04-24

Brief Summary

To determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of small airways disease in adults with chronic lung conditions compared to healthy adults, adjusting for age, sex and smoking status.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑